National Research Corp. Experiences Valuation Adjustment Amidst Market Performance Challenges

National Research Corp., a microcap company in the miscellaneous industry, has recently undergone a valuation adjustment. The company's current price stands at $11.61, with a previous close of $11.68. Over the past year, National Research has experienced a significant decline in stock performance, with a return of -41.22%, contrasting sharply with the S&P 500's return of 14.08% during the same period.
Key financial metrics for National Research include a P/E ratio of 17 and a price-to-book value of 14.27. The company's EV to EBITDA ratio is reported at 11.75, while its EV to EBIT stands at 13.79. Additionally, National Research boasts a robust return on capital employed (ROCE) of 38.17% and an impressive return on equity (ROE) of 82.18%.

In comparison to its peer, Psychemedics Corp., which has a negative P/E ratio and a lower EV to EBITDA, National Research appears to maintain a stronger financial position despite recent performance challenges. This evaluation revision reflects the ongoing dynamics within the industry and highlights the contrasting trajectories of these companies.